(Q43856707)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912024%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

HIV proteinase inhibitors: do they really work against Candida in a clinical setting? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912024%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912024%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1

Antonio Cassone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912024%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912024%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

published in

Trends in Microbiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912024%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912024%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912024%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

177-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912024%20AND%20SRC:MED&resulttype=core&format=json

In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902341-7

7 January 2021

Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902341-7

7 January 2021

Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902341-7

7 January 2021

Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902341-7

7 January 2021

Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902341-7

7 January 2021

Initial Therapy with Protease Inhibitor-Sparing Regimens: Evaluation of Nevirapine and Delavirdine

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902341-7

7 January 2021

Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902341-7

7 January 2021

Growth inhibition of Candida by human oral epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902341-7

7 January 2021

CD4+ T-helper-cell responses in mice with low-level Candida albicans infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902341-7

7 January 2021

10.1016/S0966-842X(02)02341-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912024%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference